A resource of targeted mutant mouse lines for 5,061 genes

International Mouse Phenotyping Consortium (IMPC)

Research output: Contribution to journalComment/debate

48 Scopus citations
Original languageEnglish
Pages (from-to)416-419
Number of pages4
JournalNature Genetics
Volume53
Issue number4
DOIs
StatePublished - Apr 2021

Bibliographical note

Funding Information:
We thank all technical personnel at the different centers involved in this project for their contributions. We thank G. Clarke for support with illustrations. M.-C.B., G.P., M.W.-D., Y.H. and T.S. were supported by the Université de Strasbourg, the CNRS, the INSERM and the ‘Investissements d'avenir’ programs (ANR-10-IDEX-0002-02, ANR-10-LABX-0030-INRT and ANR-10-INBS-07 PHENOMIN); A.Y. and M.T. were supported by a RIKEN BioResource Research Center (BRC), Management Expenses Grant from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); D.A., J.B., A. Bradley, W.B., B.D., S.N., R.R.S., B.R., E.R., W.S., K.S. and H.W.-J. were supported by the Wellcome Trust; S.B., S.C., G.C., M.F., S.W. and L.T. were supported by the Medical Research Council (A410); M.G., C.M. and L.N. were supported by Genome Canada and Ontario Genomics (OGI-051); H.L., Y.J.L., G.T.O. and J.K.S. were supported by the National Research Foundation (2014M3A9D5A01074636, 2014M3A9D5A01075128 and 2013M3A9D5072550), Republic of Korea (KMPC); M.B., A. Bradley, S.B., A. Bürger, W.B., F.C., M.F., A.G., M.H.d.A., R.K., S.N., G.P., R.R.S., B.R., E.R., J.S., W.S., C.S., T.S., G.T.-V., S.W., W.W. and L.T. were supported by the European Commission (EUCOMM (LSHM-CT-2005-018931), EUCOMMTOOLS (FP7-HEALTH-F4-2010-261492), EUMODIC, Infrafrontier 01KX1012 (M.H.d.A.) and EU Horizon 2020: IPAD-MD funding 653961 (M.H.d.A.)); R.S. and P.K. were supported by RVO 68378050 from the Academy of Sciences of the Czech Republic and by LM2015040 and LM2018126 (Czech Centre for Phenogenomics), CZ.1.05/2.1.00/19.0395 and CZ.1.05/1.1.00/02.0109 funded by the Ministry of Education, Youth and Sports and the European Regional Development Fund. Work was supported by the National Key R&D Program of China 2018YFA0801100 to Y.X. Research reported in this publication was supported by the NIH Common Fund, the Office of The Director and the National Human Genomic Research Institute of the National Institutes of Health (U42OD011174 supported A.L.B., J.B., A. Bradley, W.B., B.D., M.D., M.F., J. H., M.J., I.L., F.M., S.N., R.R.S., B.R., E.R., W.S., J.S., S.W. and L.T.; U42OD011175 supported M.G., C.M., L.N., B.W., J.W. and K.C.L.; U42OD011185 supported L.R.D., L.G., M.V.W. and S.A.M.; U54HG006370-02 supported A.G.-S., R.E.K., A.-M.M., T.M., V.M.F. and L.S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Cite this